Singapore: Australia's QRxPharma has received Complete Response Letter (CRL) from USFDA for its MOXDUO New Drug Applicat...
Singapore: Gilead Sciences has recieved European Commission marketing authorization approval for once-daily Tybost (cobi...
Singapore: Merck and AstraZeneca entered into a licensing agreement for Merck's oral small molecule inhibitor of WEE1 ki...
Singapore: Scientists at the Department of Pharmacy and Pharmacology, University of Bath, UK, demonstrated that anti-inf...
Australia has a long history in biomedical research, with a reputation for excellence and invention since the early 1900...
Singapore: HUYA Bioscience, a leader in globalizing China's biopharmaceutical innovations, has signed a strategic partne...
Singapore: European Commission has granted an additional indication for GlaxoSmithKline's Tyverb (lapatinib) to be used ...
Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registrati...
Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities a...
Singapore: Eli Lilly and Boehringer Ingelheim are making a slight adjustment to their diabetes alliance with respect to...
Singapore: Australia's Cellmid has completed its first in-life diabetic nephropathy study with anti-midkine antibodies (...
Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, ...
Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have c...
Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketin...
Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to s...
Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials ...
Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a glo...
Singapore: Global pharmaceutical firm, Novartis, has acquired CoStim Pharmaceuticals, a privately held biotechnology com...
